Matsuno K, Ueda K, Saito M, Kamii M, Tsuda A, Kawabata A
J Obstet Gynaecol Res. 2024; 51(1):e16141.
PMID: 39530312
PMC: 11635186.
DOI: 10.1111/jog.16141.
Guo Y, Xue L, Tang W, Xiong J, Chen D, Dai Y
Hum Reprod Update. 2024; 30(5):614-647.
PMID: 38942605
PMC: 11369228.
DOI: 10.1093/humupd/dmae020.
Kashi O, Meirow D
Int J Mol Sci. 2023; 24(22).
PMID: 38003481
PMC: 10671775.
DOI: 10.3390/ijms242216291.
Alesi L, Nguyen Q, Stringer J, Winship A, Hutt K
Reprod Fertil. 2023; .
PMID: 37068157
PMC: 10235927.
DOI: 10.1530/RAF-22-0123.
Wu C, Wu T, Chen D, Wei S, Tang W, Xue L
Front Endocrinol (Lausanne). 2022; 13:1025018.
PMID: 36531475
PMC: 9756165.
DOI: 10.3389/fendo.2022.1025018.
Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation.
Kim S, Lee S, Park H, Song J, Kim T
Genes (Basel). 2021; 12(10).
PMID: 34680919
PMC: 8535252.
DOI: 10.3390/genes12101525.
Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.
Kim S, Kim S, Han S, Lee S, Park H, Song J
Int J Mol Sci. 2021; 22(14).
PMID: 34299104
PMC: 8305189.
DOI: 10.3390/ijms22147484.
Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice.
Li J, Long H, Cong Y, Gao H, Lyu Q, Yu S
Reprod Biol Endocrinol. 2021; 19(1):63.
PMID: 33892727
PMC: 8063466.
DOI: 10.1186/s12958-021-00743-y.
Sphingosine-1-phosphate and its mimetic FTY720 do not protect against radiation-induced ovarian fibrosis in the nonhuman primate†.
Amargant F, Manuel S, Larmore M, Johnson B, Lawson M, Pritchard M
Biol Reprod. 2021; 104(5):1058-1070.
PMID: 33524104
PMC: 8111238.
DOI: 10.1093/biolre/ioab012.
Fertility in Breast Cancer Survivors in the Middle East: A Retrospective Study.
Assi H, Kakati R, Attieh R, Khoury J, Sukhon F, Berro J
Breast. 2020; 52:58-63.
PMID: 32388348
PMC: 7377329.
DOI: 10.1016/j.breast.2020.04.010.
Amenorrhea after lung cancer treatment.
Cathcart-Rake E, Ruddy K, Gupta R, Kremers W, Gast K, Su H
Menopause. 2018; 26(3):306-310.
PMID: 30153217
PMC: 6389397.
DOI: 10.1097/GME.0000000000001199.
Menstrual restoration in severe panhypopituitarism many years after cranial irradiation for suprasellar germinoma.
Ito M, Iwamoto I, Hirano H, Douchi T
Reprod Med Biol. 2017; 14(3):131-134.
PMID: 29259410
PMC: 5715822.
DOI: 10.1007/s12522-014-0200-6.
Fertility sparing approach as the standard of care in young patients with immature teratomas.
Iavazzo C, Vorgias G, Iavazzo P, Gkegkes I
J Turk Ger Gynecol Assoc. 2017; 18(1):43-47.
PMID: 28506950
PMC: 5450210.
DOI: 10.4274/jtgga.2016.0090.
Successful treatment of advanced stage yolk sac tumour of extragonadal origin: a case report and review of literature.
Rudaitis V, Mickys U, Katinaite J, Dulko J
Acta Med Litu. 2017; 23(2):110-116.
PMID: 28356797
PMC: 5088743.
DOI: 10.6001/actamedica.v23i2.3327.
Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
Bedoschi G, Navarro P, Oktay K
Future Oncol. 2016; 12(20):2333-44.
PMID: 27402553
PMC: 5066134.
DOI: 10.2217/fon-2016-0176.
Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.
Liem G, Mo F, Pang E, Suen J, Tang N, Lee K
PLoS One. 2015; 10(10):e0140842.
PMID: 26485568
PMC: 4613138.
DOI: 10.1371/journal.pone.0140842.
Outcomes of ovarian stimulation after treatment with chemotherapy.
Chan J, Johnson L, Efymow B, Sammel M, Gracia C
J Assist Reprod Genet. 2015; 32(10):1537-45.
PMID: 26400507
PMC: 4615911.
DOI: 10.1007/s10815-015-0575-2.
Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
Su H, Haunschild C, Chung K, Komrokian S, Boles S, Sammel M
Cancer. 2014; 120(23):3691-8.
PMID: 25081546
PMC: 4239183.
DOI: 10.1002/cncr.28942.
Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles.
Lopes F, Smith R, Anderson R, Spears N
Mol Hum Reprod. 2014; 20(10):948-59.
PMID: 25080441
PMC: 4172173.
DOI: 10.1093/molehr/gau057.
Maintaining the reproductive potential of cancer patients during cancer treatment.
Harp D, Chowdhury I, Garcia-Barrio M, Welch C, Matthews R, Thompson W
Front Biosci (Schol Ed). 2014; 6(1):39-49.
PMID: 24389259
PMC: 6178803.
DOI: 10.2741/s412.